ARCHIVES

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975